1887

Journal of General Virology header logo

Volume 41, Issue 3

Neutralization of Mason–Pfizer Virus by Sera from Patients Treated for Renal Disease Free

Abstract

SUMMARY

Sera from 67 patients treated for renal diseases were assayed by as many as three different tests for activities against Mason–Pfizer virus (M–PV) antigens. Firstly, in patients studied before kidney transplantation, neutralizing activity against syncytium-forming units of M–PV was found in 50% of 24 cases of chronic glomerulonephritis but in only 10% of 20 cases with other diseases ( < 0.01). These proportions were higher after treatments accompanying transplantation since, of the 19 patients without antibodies before graft, 53% showed a seroconversion after this treatment. The incidence of M–PV antibodies did not correlate with the number of transfusions received by the patients. Neither did these antibodies correlate with the presence of antibodies to antigens associated with baboon endogenous virus or simian sarcoma virus; antibodies to the latter two viruses were found in 6 to 21% of the sera, with no specific distribution among the sera. Secondly, pseudotypes of vesicular stomatitis virus with M–PV antigens in their envelope were prepared; they were inactivated by 90% of the sera which neutralized M–PV syncytium forming units and by none of the negative sera. Thirdly, specific complement-dependent cytotoxic antibodies to HeLa cells producing M–PV were also found in 61% of the sera with neutralizing activity to M–PV and only in 12% of the sera which did not neutralize M–PV. Absorption experiments indicated that the serum activities against M–P V associated antigens were not due to anticellular antibodies directed against normal constituents of human cells. However, no evidence has been provided that the M–PV associated antigens reacting with the human sera were virus coded.

  • Received:
  • Accepted:
  • Published Online:
© Society for General Microbiology 1978
Loading

Article metrics loading...

/content/journal/jgv/10.1099/0022-1317-41-3-587
1978-12-01
2024-04-24
Loading full text...

Full text loading...

/deliver/fulltext/jgv/41/3/JV0410030587.html?itemId=/content/journal/jgv/10.1099/0022-1317-41-3-587&mimeType=html&fmt=ahah

References

  1. Ahmed M., Korol W., Ych J., Schidlovsky G., Mayyasi S. A. 1974; Detection of Mason–Pfizer infection with human KC cells carrying Rous virus genome. Journal of National Cancer Institute 53:383–387
     [Google Scholar]
  2. Ahmed M., Karol W., Larson K. L., Harewood K. R., Mayyasi S. A. 1975; Interactions between endogenous baboon type C virus and oncogenic viruses. I. Syncytium induction and development of in-fectivity assay. International Journal of Cancer 16:747–755
     [Google Scholar]
  3. Alstein A. D., Zhdanov V. M., Omelchenko T. N., Dzagurov S. G., Miller G. G., Zavada J. 1976; Phenotypic mixing of vesicular stomatitis virus and D-type oncornavirus. International Journal of Cancer 17:780–784
     [Google Scholar]
  4. Aoki T., Walling M. J., Bushar G. S., Liu M., Hsu K. C. 1976; Natural antibodies in sera from healthy humans to antigens on surfaces of type C RNA viruses and cells of primates. Proceedings of the National Academy of Sciences of the United States of America 73:2491–2495
     [Google Scholar]
  5. Charman H. P., Rahman R., White M. H., Kim N., Gilden R. V. 1977; Radioimmunoassay for the major structural protein of Mason–Pfizer monkey virus: attempts to detect the presence of antigen or antibody in humans. International Journal of Cancer 19:498–504
     [Google Scholar]
  6. Fischinger P. J., Ihle J. N., Bolognesi D. P., Schafer W. 1976; Inactivation of murine xenotropic oncornavirus by normal mouse sera is not immunoglobulin mediated. Virology 71:346–351
     [Google Scholar]
  7. Gelderblom H., Bauer H., Ogura H., Wigand R., Fischer A. B. 1974; Detection of oncornavirus-like particles in HeLa cells. I. Fine structure and comparative morphological classification. International Journal of Cancer 13:246–253
     [Google Scholar]
  8. Hirsch M. S., Black P. H., Tracy G. S., Leibowitz S., Schwartz R. S. 1970; Leukemia virus activation in chronic allogeneic disease. Proceedings of the National Academy of Sciences of the United States of America 67:1914–1917
     [Google Scholar]
  9. Hirsch M. S., Phillips S. M., Solnik C., Black P. H., Schwartz R. S., Carpenter C. B. 1972; Activation of leukemia viruses by graft versus host and mixed lymphocyte reactions in vitro . Proceedings of the National Academy of Sciences of the United States of America 69:1069–1072
     [Google Scholar]
  10. Hirsch M. S., Ellis D. A., Black P. H., Monaco A. P., Wood M. L. 1973; Leukemia virus activation during homograft rejection. Science, New York 180:500–502
     [Google Scholar]
  11. Hirsch M. S., Ellis D. A., Kelly A. P., Profitt M. R., Black P. H., Monaco A. P., Wood M. L. 1975; Activation of C-type viruses during skin graft rejection in the mouse. Interrelationships between irnrmmostimulation and immunosuppression. International Journal of Cancer 15:493–502
     [Google Scholar]
  12. Irie R. F., Irie K., Morton K. L. 1974; Natural antibody in human serum to a neoantigen in human cultured cells grown in fetal bovine serum. Journal of the National Cancer Institute 52:1051–1058
     [Google Scholar]
  13. Kawakami T. G., Huff S. E., Buckley P. M., Dungworth D. C., Snyder S. P., Gilden R. V. 1972; Type C virus associated with gibbon lymphosarcoma. Nature New Biology 235:170–171
     [Google Scholar]
  14. Kurth R., Medley G. 1975; A membrane permeability test for the detection of cell surface antigens. Immunology 29:803–811
     [Google Scholar]
  15. Kurth R., Teich N. M., Weiss R., Oliver R. T. D. 1977; Natural human antibodies reactive with primate type-C viral antigens. Proceedings of the National Academy of Sciences of the United States of America 74:1237–1241
     [Google Scholar]
  16. Mellors R. C., Mellors J. W. 1976; Antigen related to mammalian type C RNA viral p 30 proteins is located in renal glomeruli in human systemic lupus erythematosus. Proceedings of the National Academy of Sciences of the United States of America 73:233–237
     [Google Scholar]
  17. Ohno T., Sweet R. W., Hu R., Dejak D., Spiegelman S. 1977; Purification and characterization of the DNA polymerase of human breast cancer particles. Proceedings of the National Academy of Sciences of the United States of America 74:764–768
     [Google Scholar]
  18. Panem S., Ordonez N. G., Kirsten W. H., Katz A. I., Spargo B. H. 1976; C-type virus expression in systemic lupus erythematosus. New England Journal of Medicine 295:470–475
     [Google Scholar]
  19. Rand K. H., Long C. 1972; Syncytial assay for the putative human C-type virus RD 114 utilizing normal cells transformed by Rous sarcoma virus. Nature New Biology 240:187–190
     [Google Scholar]
  20. Schochetman G., Kortright K., Schlom J. 1975; Mason-Pfizer monkey virus: analysis and localization of virion proteins and glycoproteins. Journal of Virology 16:1208–1219
     [Google Scholar]
  21. Snyder H. W., Pincus T., Fleissner E. 1976; Specificities of human immunoglobulins reactive with antigens in preparations of several mammalian type-C viruses. Virology 75:60–73
     [Google Scholar]
  22. Snyder H. W., Fox M. 1978; Characterization of a fetal calf serum-derived molecule reactive with human natural antibodies: its occurrence in tissue-culture grown type C RNA viruses. Journal of Immunology 120:646–651
     [Google Scholar]
  23. Stephenson J. R., Aaronson S. A. 1976; Search for antigens and antibodies crossreactive with type C viruses of the woolly monkey and gibbon ape in animal models and in humans. Proceedings of the National Academy of Sciences of the United States of America 73:1725–1729
     [Google Scholar]
  24. Thiry L., Sprecher-Goldberger S., Vandenbussche P., Bossens M., Vereerstraeten P., Hestermans-medard O. 1978a; Mason–Pfizer like virus in kidney grafted patients. Medical Microbiology and Immunology (in the press)
     [Google Scholar]
  25. Thiry L., Sprecher-goldberger S., Bossens M., Neuray P. 1978b; Cell-mediated immune response to Simian Oncornavirus antigens in pregnant women. Journal of the National Cancer Institute 60:527–532
     [Google Scholar]
  26. Thiry L., Cogniaux-le clerc J., Content J., Tack L. 1978c; Factors which influence inactivation of vesicular stomatitis virus by fresh human serum. Virology 87:384–393
     [Google Scholar]
  27. Welsch R. M., Jensen F. C., Cooper N. R., Oldstone M. B. A. 1976; Inactivation and lysis of oncorna-viruses by human serum. Virology 74:432–440
     [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/0022-1317-41-3-587
Loading
Neutralization of Mason–Pfizer Virus by Sera from Patients Treated for Renal Disease
J. Gen. Virol. 41, 587 (1978); https://doi.org/10.1099/0022-1317-41-3-587
/content/journal/jgv/10.1099/0022-1317-41-3-587
/content/journal/jgv/10.1099/0022-1317-41-3-587
Loading

Data & Media loading...

Most cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error